SMTL ID : 4bck.1 (1 other biounit)

Structure of CDK2 in complex with cyclin A and a 2-amino-4-heteroaryl- pyrimidine inhibitor

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.05 Å

Oligo State

hetero-oligomer

Ligands

1 x T3E: 3-[[5-CYANO-4-[4-METHYL-2-(METHYLAMINO)-1,3-THIAZOL-5-YL]PYRIMIDIN-2-YL]AMINO]BENZENESULFONAMIDE

T3E.1: 18 residues within 4Å: Chain A: I.12, E.14, G.15, V.20, A.33, K.35, V.66, F.82, E.83, F.84, L.85, H.86, Q.87, D.88, K.91, Q.133, L.136, D.147 6 PLIP interactions: 6 interactions with chain A Hydrophobic interactions: A:I.12, A:F.82, A:L.136 Hydrogen bonds: A:L.85, A:D.88, A:D.88

1 x SGM: MONOTHIOGLYCEROL(Non-covalent)

SGM.2: 4 residues within 4Å: Chain A: C.179, K.180, M.235, P.236 No protein-ligand interaction detected (PLIP)

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Hole, A.J. et al., Comparative Structural and Functional Studies of 4-(Thiazol- 5-Yl)-2-(Phenylamino)Pyrimidine-5-Carbonitrile Cdk9 Inhibitors Suggest the Basis for Isotype Selectivity. J.Med.Chem. (2013)

Release Date

2013-03-06

Peptides

CYCLIN-DEPENDENT KINASE 2: A
CYCLIN-A2: B

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

CYCLIN-DEPENDENT KINASE 2

CYCLIN-A2

Related Entries With Identical Sequence